PUBLICATION

Caffeine reduces hepatic lipid accumulation through regulation of lipogenesis and ER stress in zebrafish larvae

Authors
Zheng, X., Dai, W., Chen, X., Wang, K., Zhang, W., Liu, L., Hou, J.
ID
ZDB-PUB-151119-15
Date
2015
Source
Journal of Biomedical Science   22: 105 (Journal)
Registered Authors
Chen, Xiaohui
Keywords
Caffeine, Zebrafish, Fatty, Liver, ER Stress, Lipogenesis
MeSH Terms
  • Liver/metabolism*
  • Zebrafish/genetics
  • Zebrafish/metabolism*
  • Humans
  • Caffeine/pharmacology*
  • Lipids/biosynthesis*
  • Lipids/genetics
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism
  • Animals
  • Endoplasmic Reticulum Stress/drug effects*
  • Endoplasmic Reticulum Stress/genetics
  • Non-alcoholic Fatty Liver Disease/genetics
  • Non-alcoholic Fatty Liver Disease/metabolism
  • Non-alcoholic Fatty Liver Disease/prevention & control
  • Lipogenesis/drug effects*
  • Lipogenesis/genetics
(all 17)
PubMed
26572131 Full text @ J. Biomed. Sci.
Abstract
Caffeine, the main component of coffee, has showed its protective effect on non-alcoholic fatty liver disease (NAFLD) in many studies. However, the hepatoprotection of caffeine and its mechanisms in zebrafish were unexplored. Thus, this study's intentions are to establish a NAFLD model of zebrafish larvae and to examine the role of caffeine on fatty liver with the model.
Growth and the incidence of fatty liver of zebrafish larvae increased with the increased amount of feeding in a dose-dependent manner. The degree of hepatic steatosis of larvae also gradually aggravated with the increased quantity and duration of feeding. Triglyceride contents of zebrafish fed for 20 days significantly increased in model group (180 mg/d) compared with control group (30 mg/d) (P < 0.001). Significant decreases in body weight and hepatic steatosis rate were observed in 2.5, 5, 8 % caffeine treatment group compared with model group (P < 0.05). Hepatic lipid accumulation was also significantly reduced in caffeine treatment larvae. Moreover, caffeine treatment was associated with upregulation of lipid β-oxidation gene ACO and downregulation of lipogenesis-associated genes (SREBP1, ACC1, CD36 and UCP2), ER stress-associated genes (PERK, IRE1, ATF6 and BIP), the inflammatory cytokine genes (IL-1beta and TNF-alpha) and autophagy associated genes (ATG12 and Beclin-1). Protein expression of CHOP, BIP and IL-1beta remarkably reduced in caffeine treatment group compared with model group.
We induced hepatoteatosis in zebrafish by overfeeding regimen and demonstrated caffeine have a role in suppression of hepatosteatosis by downregulation of genes associated with lipogenesis, ER stress, inflammatory response and enhancement of lipid oxidation, indicating zebrafish model may be used to identify putative pharmacological targets and to test novel drugs for human NAFLD treatment.
Genes / Markers
Figures
Figure Gallery (5 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
No data available
Human Disease / Model
Human Disease Fish Conditions Evidence
steatotic liver diseaseWTunlimited food availabilityTAS
1 - 1 of 1
Show
Sequence Targeting Reagents
No data available
Fish
Fish
WT
1 - 1 of 1
Show
Antibodies
Name Type Antigen Genes Isotypes Host Organism
Ab2-ddit3polyclonal
    Rabbit
    Ab2-il1bpolyclonal
      IgGRabbit
      Ab5-hspa5monoclonal
        Mouse
        1 - 3 of 3
        Show
        Orthology
        No data available
        Engineered Foreign Genes
        No data available
        Mapping
        No data available